# A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors

> **NCT01090960** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 52 (actual)

## Conditions studied

- Solid Cancers

## Interventions

- **DRUG:** GDC-0068

## Key facts

- **NCT ID:** NCT01090960
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2016-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01090960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01090960, "A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01090960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*